Fiche centre
Helsinki University Central Hospital
Helsinki — Finland
Essais liés3clinical trials
VilleHelsinkilocalisation
PaysFinlandlocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT03436485
Essais cliniques associés
3| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| ODM-208 | Cancer | Phase 1/2 | NCT03436485 | CYPIDES — Safety and Pharmacokinetics of ODM-208 in Patients With Metastatic Castration-resistant Prostate Cancer | ACTIVE_NOT_RECRUITING |
| Fenebrutinib | SEP | Phase 3 | NCT04586010 | FENhance — A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Teriflunomide in Relapsing Multiple Sclerosis (RMS) | ACTIVE_NOT_RECRUITING |
| Limb salvage | Myopathies | À vérifier | NCT02380651 | Functional Outcomes and HRQoL in Upper-extremity Sarcoma Patients After Limb Salvage | COMPLETED |